Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

OBJECTIVE: Intravenous methylprednisolone is the standard treatment for a multiple sclerosis relapse; however, this fails to improve symptoms in up to one quarter of patients. Immunoadsorption is an accepted treatment for refractory relapses, but prospective comparator-controlled studies are missing...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeuffer, Steffen, Rolfes, Leoni, Wirth, Timo, Steffen, Falk, Pawlitzki, Marc, Schulte-Mecklenbeck, Andreas, Gross, Catharina C., Brand, Marcus, Bittner, Stefan, Ruck, Tobias, Klotz, Luisa, Wiendl, Heinz, Meuth, Sven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450381/
https://www.ncbi.nlm.nih.gov/pubmed/36071461
http://dx.doi.org/10.1186/s12974-022-02583-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450381/
https://www.ncbi.nlm.nih.gov/pubmed/36071461
http://dx.doi.org/10.1186/s12974-022-02583-y

Ejemplares similares